We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.48B
AUM Growth
+$119M
Cap. Flow
+$156M
Cap. Flow %
6.28%
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
191

Sector Composition

Rank Sector Weight
1 Technology 15.89%
2 Financials 8.07%
3 Healthcare 5.89%
4 Consumer Discretionary 5.37%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAIC icon
2926
Saic
SAIC
$5.35B
$1K ﹤0.01%
+12
New +$1.03K
FLNA
2927
Filana Therapeutics
FLNA
$48.1M
$1K ﹤0.01%
20
SCS
2928
DELISTED
Steelcase
SCS
$1K ﹤0.01%
48
-96
-67% -$1.32K
SKY icon
2929
Champion Homes
SKY
$5.14B
$1K ﹤0.01%
+10
New +$592
SLDB icon
2930
Solid Biosciences
SLDB
$900M
$1K ﹤0.01%
+19
New +$807
SLQT icon
2931
SelectQuote
SLQT
$121M
$1K ﹤0.01%
+66
New +$994
SMPL icon
2932
Simply Good Foods
SMPL
$982M
$1K ﹤0.01%
36
FTH
2933
Faeth Therapeutics
FTH
$629M
$1K ﹤0.01%
+3
New +$546
SOHU
2934
Sohu.com
SOHU
$357M
$1K ﹤0.01%
35
+33
+1,650% +$705
SPMD icon
2935
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.9B
$1K ﹤0.01%
25
SRRK icon
2936
Scholar Rock
SRRK
$6.44B
$1K ﹤0.01%
+19
New +$665
STEL
2937
DELISTED
Stellar Bancorp
STEL
$1K ﹤0.01%
50
STR
2938
DELISTED
Sitio Royalties
STR
$1K ﹤0.01%
54
-43
-44% -$802
TARS icon
2939
Tarsus Pharmaceuticals
TARS
$2.84B
$1K ﹤0.01%
+44
New +$1.09K
TGI
2940
DELISTED
Triumph Group
TGI
$1K ﹤0.01%
64
+19
+42% +$354
THO icon
2941
Thor Industries
THO
$4.14B
$1K ﹤0.01%
9
-11
-55% -$1.26K
TILE icon
2942
Interface
TILE
$2.22B
$1K ﹤0.01%
55
TPB icon
2943
Turning Point Brands
TPB
$1.74B
$1K ﹤0.01%
25
TPIC
2944
DELISTED
TPI Composites
TPIC
$1K ﹤0.01%
38
-27
-42% -$1.06K
TPL icon
2945
Texas Pacific Land
TPL
$23.5B
$1K ﹤0.01%
+9
New +$1.4K
TSEM icon
2946
Tower Semiconductor
TSEM
$28.5B
$1K ﹤0.01%
+23
New +$662
TSLX icon
2947
Sixth Street Specialty
TSLX
$1.81B
$1K ﹤0.01%
58
+22
+61% +$504
TXG icon
2948
10x Genomics
TXG
$6.61B
$1K ﹤0.01%
10
-1
-9% -$172
UFPT icon
2949
UFP Technologies
UFPT
$2.43B
$1K ﹤0.01%
+19
New +$1.2K
URGN icon
2950
UroGen Pharma
URGN
$2.29B
$1K ﹤0.01%
47

Similar funds

Parallel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $156M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.

  • Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
  • Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
  • Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
  • Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
  • Parallel Advisors opened 363 new positions and closed 191 in Q3 2021.
  • Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.

Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.